临床外科杂志 ›› 2023, Vol. 31 ›› Issue (5): 440-443.doi: 10.3969/j.issn.1005-6483.2023.05.011

• 论著 • 上一篇    下一篇

膀胱癌组织中miR-144、肺癌转移相关转录本1及睾丸蛋白聚糖表达及其诊断价值

  

  1. 629000  四川省遂宁市中心医院泌尿外科 
  • 收稿日期:2022-09-19 修回日期:2022-09-19 出版日期:2023-05-20 发布日期:2023-05-20
  • 通讯作者: 何俊,Eamil:easret@163.com

Expression and diagnostic value of miR-144,MALAT1 and SPOCK1 in bladder cancer tissue

  1. Department of Urology,Suining Central Hospital,Sichuan,Suining 629000,China
  • Received:2022-09-19 Revised:2022-09-19 Online:2023-05-20 Published:2023-05-20

摘要: 目的 分析膀胱癌组织中miR-144、肺癌转移相关转录本1(MALA T1)及睾丸蛋白聚糖(SPOCK1)表达及其诊断价值。方法 2018年1月~2021年1月本院收治的膀胱尿路上皮癌病人96例,膀胱电切或膀胱根治性切除留取膀胱癌病人新鲜肿瘤组织(肿瘤组)及距离肿瘤边缘>2cm癌旁正常组织(癌旁组)标本,各5mg。使用聚合酶链式反应(PCR)检测不同组织中miR-144、MALAT1及SPOCK1相对表达量,分析miR-144、MALAT1及SPOCK1在不同膀胱癌病理特征中表达情况,绘制ROC曲线,检验miR-144、MALAT1、SPOCK1对膀胱癌的诊断价值。96例病人均在本院进行外科手术+术后辅助化疗,通过电话和门诊随访等方式对病人进行随访,随访截止至2022年1月30日,比较不同预后者miR-144、MALAT1及SPOCK1的表达。结果 肿瘤组中MALAT1及SPOCK1相对表达量高于癌旁组,而miR-144相对表达量则低于癌旁组,差异有统计学意义(P<0.05)。Ⅲ~Ⅳ期、有淋巴结转移者miR-144表达低于Ⅰ~Ⅱ期、无淋巴结转移者,差异有统计学意义(P<0.05),Ⅲ~Ⅳ期、低分化、有淋巴结转移者MALAT1、SPOCK表达高于Ⅰ~Ⅱ期、中高分化与无淋巴结转移者,差异有统计学意义(P<0.05)。miR-144、MALAT1及SPOCK1对膀胱癌诊断AUC值分别为0.643、0.557,SPOCK1诊断AUC值为0.717(95%Cl:0.688~0.845),以SPOCK1诊断AUC值最高(P<0.05)。96例病人预后良好85例,预后不良11例。预后不良组miR-144低于预后良好组,MALAT1及SPOCK1高于预后良好组,差异有统计学意义(P<0.05)。结论膀胱癌组织中miR-144、MALAT1及SPOCK1表达异常,与病人病理特征存在一定联系,或可作为膀胱癌潜在诊断标志物。

关键词: 膀胱癌, miR-144, 肺癌转移相关转录本1, 睾丸蛋白聚糖, 分化程度, 病理特征

Abstract: Objective To analyze the expression of miR-144,lung cancer metastasis-associated transcript 1 (MALA T1) and testis proteoglycan (SPOCK1) in bladder cancer tissues and their diagnostic efficacy.Methods A total of 96 bladder cancer patients who were treated in our hospital from January 2018 to January 2021 were selected.Fresh tumor tissue from bladder cancer patients (tumor group) and normal tissue adjacent to the tumor > 2 cm away from the tumor edge (paracancerous group) were collected during surgery.5 mg each.The relative expression levels of miR-144,MALAT1 and SPOCK1 in different tissues were detected by polymerase chain reaction (PCR),and the expressions of miR-144,MALAT1 and SPOCK1 in different pathological features of bladder cancer were analyzed.The ROC curve was drawn to test the diagnostic effect of miR-144,MALAT1 and SPOCK1 on bladder cancer.96 patients underwent surgery + postoperative adjuvant chemotherapy in our hospital,and the patients were followed up by telephone and outpatient followup.Followup ended on January 30,2022,and the expressions of miR-144,MALAT1 and SPOCK1 were compared in patients with different prognosis.Results The relative expressions of MALAT1 and SPOCK1 in the tumor group were significantly higher than those in the paracancerous group,while the relative expression of miR-144 was significantly lower than that in the control group (P<0.05).The expression of miR-144 in stage Ⅲ-Ⅳ patients with lymph node metastasis was significantly lower than that in stage Ⅰ-Ⅱ patients without lymph node metastasis(P<0.05).MALAT1 and SPOCK levels in stage Ⅲ-Ⅳ,poorly differentiated,and lymph node metastasis were significantly higher than those in stage Ⅰ-Ⅱ,moderately and well differentiated,and no lymph node metastasis (P<0.05).The ROC curve was drawn,and the AUC value was calculated.The AUC values of miR-144,MALAT1 and SPOCK1 for the diagnosis of bladder cancer were 0.643 and 0.557,respectively,and the AUC value for the diagnosis of SPOCK1 was 0.717 (95%Cl:0.688-0.845).the highest AUC value was diagnosed with SPOCK1 (P<0.05).Follow-up data showed that 85 of 96 patients had good prognosis and 11 had poor prognosis.The miR-144 in the poor prognosis group was significantly lower than that in the good prognosis group,and MALAT1 and SPOCK1 were significantly higher than those in the good prognosis group (P<0.05).Conclusion The abnormal expression of miR-144,MALAT1 and SPOCK1 in bladder cancer tissue has a certain relationship with the pathological characteristics of patients,and may be used as potential diagnostic markers for bladder cancer.

Key words: bladder cancer, MiR-144, lung cancer metastasis-associated transcript 1, testis proteoglycan, degree of differentiation, pathological features

[1] 管富勇 王黎 王俊霖 姚启盛. 非肌层浸润性膀胱癌经尿道膀胱肿瘤电切术后肿瘤残余病人行二次电切术后复发的危险因素分析[J]. 临床外科杂志, 2023, 31(2): 127-131.
[2] 陈勇伟 李昊 黄力 陈从波 王黎 姚启盛. 新辅助化疗联合经尿道膀胱肿瘤电切术对膀胱癌病人肿瘤直径、尿液膀胱肿瘤抗原水平及复发率的影响[J]. 临床外科杂志, 2023, 31(2): 152-155.
[3] 刘琦 万玉文 李晓强. 椎管内麻醉联合超声引导下闭孔神经阻滞与全身麻醉相比对经尿道膀胱肿瘤切除术病人术后肿瘤复发影响的临床研究进展[J]. 临床外科杂志, 2022, 30(6): 506-509.
[4] 姚宝春 邓大溢 方强 陈士洲. 激光与电切术治疗非肌层浸润性膀胱癌的疗效及应激反应程度比较[J]. 临床外科杂志, 2022, 30(6): 579-582.
[5] 叶彬 向秋 金文杰. 叉头框蛋白Q1和细胞周期蛋白D1在非小细胞肺癌组织中的表达与临床病理特征及预后的关系[J]. 临床外科杂志, 2022, 30(5): 453-458.
[6] 李铃睿 宋俊龙 刘汉卿 孔德光 陈创. 甲状腺乳头状癌的基因变异与临床病理特点分析[J]. 临床外科杂志, 2022, 30(3): 222-225.
[7] 张顺 丁秋播 庄君龙. 膀胱癌新辅助免疫治疗引起免疫相关性膀胱炎二例[J]. 临床外科杂志, 2022, 30(3): 276-279.
[8] 李玉柱 夏连杰. 膀胱癌病人癌组织中Dickkopf相关蛋白2的表达及与预后的相关性[J]. 临床外科杂志, 2022, 30(3): 280-283.
[9] 李云龙 杜正华 张慧敏 解凤妮 李纪鹏. 胃肠胰神经内分泌肿瘤临床治疗及预后分析[J]. 临床外科杂志, 2022, 30(2): 166-170.
[10] 许伟杰 李金雨 林联拯 赵力 于忠英 朱显钟. 经尿道等离子电切镜逆行黏膜下膀胱肿瘤整块剜切术对非肌层浸润性膀胱癌病人的出血量及氧化应激因子的影响 [J]. 临床外科杂志, 2022, 30(12): 1187-1190.
[11] 何领 徐鲲 任明 陈晨 郭嵩 朱太阳 陈德轩 高国宇 王高元. 伴桥本甲状腺炎的甲状腺乳头状癌临床病理特征及其手术策略[J]. 临床外科杂志, 2022, 30(1): 40-43.
[12] 姜小琴 李惠珍. 经尿道膀胱肿瘤电切术同期经尿道前列腺电切术治疗非浸润性膀胱癌伴良性前列腺增生的安全性及有效性研究[J]. 临床外科杂志, 2021, 29(9): 872-875.
[13] 李连红, 施柳辉, 施飞等. 非肌层浸润性膀胱癌病人在膀胱灌注化疗期间性功能状况的影响因素分析[J]. 临床外科杂志, 2021, 29(4): 372-375.
[14] 邴钟兴 郑志博 张家齐. 非小细胞肺癌组织驱动蛋白超家族成员2A、真核起始因子3b的mRNA表达及其临床意义[J]. 临床外科杂志, 2021, 29(12): 1123-1126.
[15] 奉琴 刘玲 何其英 周艳 范冬萍. 互联网+自我管理模式对膀胱癌行回肠膀胱造口病人延续期生活质量的影响研究[J]. 临床外科杂志, 2021, 29(10): 971-975.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 邱江. 心脏死亡捐献供肾移植免疫抑制方案的选择[J]. 临床外科杂志, 2016, 24(10): 735 .
[2] 林俊. 原发性中枢神经系统恶性肿瘤供者在器官移植中的应用[J]. 临床外科杂志, 2016, 24(10): 737 .
[3] 昌盛. 中国心脏死亡捐献供肾器官的维护[J]. 临床外科杂志, 2016, 24(10): 744 .
[4] 阿布力克木·毛拉尤甫;郑秉礼. 胰腺实性假乳头状瘤45例手术治疗分析[J]. 临床外科杂志, 2016, 24(10): 764 .
[5] 宋华;单若冰;张晋绥;等. 产前超声诊断对新生儿消化道梗阻性疾病手术治疗价值的观察[J]. 临床外科杂志, 2016, 24(10): 780 .
[6] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .
[7] 陈绍站;许勇;李婧;等. 防旋股骨近端髓内针与股骨近端解剖锁定钢板治疗转子间骨折的疗效比较[J]. 临床外科杂志, 2016, 24(10): 787 .
[8] 戴强;徐康;周治军;等. 湖北天门地区泌尿系结石成分及特征分析[J]. 临床外科杂志, 2016, 24(10): 789 .
[9] 刘琼;江辉. 喉罩在小儿舌系带矫正手术中的应用[J]. 临床外科杂志, 2016, 24(10): 792 .
[10] 周观金;彭昊;陈森. 全膝关节置换治疗膝关节炎术后早期镇痛的研究进展[J]. 临床外科杂志, 2016, 24(10): 804 .